Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Pyridostigmine Bromide. Always confirm against the full prescribing information.
100 interactions
Acebutolol
Pyridostigmine may increase the bradycardic activities of Acebutolol.
Level 2 evidence
Aclidinium
Pyridostigmine may increase the neuromuscular blocking activities of Aclidinium.
Level 2 evidence
Amifampridine
The risk or severity of adverse effects can be increased when Pyridostigmine is combined with Amifampridine.
Level 2 evidence
Atenolol
Pyridostigmine may increase the bradycardic activities of Atenolol.
Level 2 evidence
Benzonatate
Pyridostigmine may increase the neuromuscular blocking activities of Benzonatate.
Level 2 evidence
Betaxolol
Pyridostigmine may increase the bradycardic activities of Betaxolol.
Level 2 evidence
Bisoprolol
Pyridostigmine may increase the bradycardic activities of Bisoprolol.
Level 2 evidence
Carvedilol
Pyridostigmine may increase the bradycardic activities of Carvedilol.
Level 2 evidence
Abacavir
Abacavir may increase the hepatotoxic activities of Pyridostigmine.
Level 2 evidence
Abatacept
Pyridostigmine may increase the hepatotoxic activities of Abatacept.
Level 2 evidence
Abemaciclib
Pyridostigmine may increase the hepatotoxic activities of Abemaciclib.
Level 2 evidence
Abiraterone
Abiraterone may increase the hepatotoxic activities of Pyridostigmine.
Pyridostigmine Bromide has 594 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Pyridostigmine Bromide has 1 major, 29 moderate, and 564 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Pyridostigmine Bromide. Always confirm against the full prescribing information.